Fresenius Kabi recalls sodium acetate injection

Mar 09, 2022 - 02:27 PM
FDA-device-recall

Fresenius Kabi USA Monday recalledseven lots of sodium acetate injection after finding particulate matter in sample vials, which could cause infection or other serious adverse events if administered. No adverse events were reported. Hospitals should not use the recalled product, a sodium additive for intravenous fluids.  

Related News Articles

Headline
AHA provides recommendations to Consumer Product Safety Commission on modernized product injury surveillance system
The AHA today provided comments to the Consumer Product Safety Commission on its agenda and priorities for fiscal years 2027 and 2028, specifically…
Headline
Highest FDA recall issued for certain convenience kits
The Food and Drug Administration Aug. 3 identified Class I recalls of two convenience kit products. Certain kits by Medline…
Headline
FDA identifies, issues Class 1 recalls
The Food and Drug Administration has identified a recall by Cook Medical of Zenith Alpha 2 Thoracic Endovascular Graft proximal components after Cook Medical…
Headline
FDA issues early alerts for certain Baxter, Abiomed products
The Food and Drug Administration has issued early alerts for certain Spectrum infusion pumps from Baxter and Abiomed Automated Impella Controllers. The agency…
Headline
FDA approves first semiannual HIV prevention drug
The Food and Drug Administration has approved a new, first-of-its-kind semiannual HIV prevention medication, Gilead Sciences announced June 18. The company…
Headline
White House announces tariffs on goods imported from Canada, Mexico, China
The White House Feb. 1 announced it placed tariffs on imported goods from Canada, Mexico and China. The tariffs for Mexico and Canada have since been delayed…